{"disease":{"id":"familial-hypertriglyceridemia","name":"familial hypertriglyceridemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06104943","title":"Stockholm hyperTRIglyceridemia REGister (STRIREG) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3607819,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT03747224","title":"Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":false},{"nct_id":"NCT05851066","title":"A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Visirna Therapeutics HK Limited","has_results":false},{"nct_id":"NCT03508687","title":"Study of Gemcabene in Adults With FPLD","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Elif Oral","has_results":true},{"nct_id":"NCT06796426","title":"Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":false},{"nct_id":"NCT06500598","title":"Compassionate Use of Evinacumab","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}